9-134789254-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000093.5(COL5A1):c.2700+46C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0471 in 1,526,274 control chromosomes in the GnomAD database, including 1,842 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 150 hom., cov: 32)
Exomes 𝑓: 0.048 ( 1692 hom. )
Consequence
COL5A1
NM_000093.5 intron
NM_000093.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.34
Publications
4 publications found
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 9-134789254-C-T is Benign according to our data. Variant chr9-134789254-C-T is described in ClinVar as Benign. ClinVar VariationId is 255068.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0545 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.2700+46C>T | intron_variant | Intron 32 of 65 | ENST00000371817.8 | NP_000084.3 | ||
| COL5A1 | NM_001278074.1 | c.2700+46C>T | intron_variant | Intron 32 of 65 | NP_001265003.1 | |||
| COL5A1 | XM_017014266.3 | c.2700+46C>T | intron_variant | Intron 32 of 64 | XP_016869755.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0382 AC: 5811AN: 152128Hom.: 150 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5811
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0417 AC: 9961AN: 238944 AF XY: 0.0421 show subpopulations
GnomAD2 exomes
AF:
AC:
9961
AN:
238944
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0481 AC: 66090AN: 1374028Hom.: 1692 Cov.: 22 AF XY: 0.0475 AC XY: 32685AN XY: 687932 show subpopulations
GnomAD4 exome
AF:
AC:
66090
AN:
1374028
Hom.:
Cov.:
22
AF XY:
AC XY:
32685
AN XY:
687932
show subpopulations
African (AFR)
AF:
AC:
243
AN:
31718
American (AMR)
AF:
AC:
926
AN:
44088
Ashkenazi Jewish (ASJ)
AF:
AC:
1085
AN:
25420
East Asian (EAS)
AF:
AC:
15
AN:
39206
South Asian (SAS)
AF:
AC:
1640
AN:
83872
European-Finnish (FIN)
AF:
AC:
3812
AN:
50968
Middle Eastern (MID)
AF:
AC:
233
AN:
5582
European-Non Finnish (NFE)
AF:
AC:
55641
AN:
1035836
Other (OTH)
AF:
AC:
2495
AN:
57338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3222
6443
9665
12886
16108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1926
3852
5778
7704
9630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0382 AC: 5810AN: 152246Hom.: 150 Cov.: 32 AF XY: 0.0386 AC XY: 2869AN XY: 74414 show subpopulations
GnomAD4 genome
AF:
AC:
5810
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
2869
AN XY:
74414
show subpopulations
African (AFR)
AF:
AC:
358
AN:
41554
American (AMR)
AF:
AC:
424
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
170
AN:
3472
East Asian (EAS)
AF:
AC:
7
AN:
5178
South Asian (SAS)
AF:
AC:
94
AN:
4822
European-Finnish (FIN)
AF:
AC:
828
AN:
10590
Middle Eastern (MID)
AF:
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3805
AN:
68016
Other (OTH)
AF:
AC:
84
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
283
566
850
1133
1416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
60
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.